Vc Thoughts, Health, Dna, Rna, Healthcare.
manufacturing further impede the seamless transition from laboratory research to clinical application. In 2021, only 40 of the 538 in vivo genomic medicine assets (encompassing gene addition or replacement, gene expression control, gene editing, and DNA/RNA vaccines) were administered using LNPs.